Physician profile
Anthony Sanito
NPI 1033189931
$2,417.65
in general payments reported to CMS, 2019-2025
17 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $148 · 2021: $243 · 2022: $407 · 2023: $510 · 2024: $319 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $747.61 | 2019-2025 | Xtampza, Belbuca |
| Boston Scientific Corporation | $291.19 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $282.41 | 2021-2025 | Eterna, Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $255.33 | 2021-2024 | Relistor |
| Nevro Corp. | $234.14 | 2019-2022 | |
| Daiichi Sankyo INC. | $103.34 | 2019 | |
| Spr Therapeutics, INC | $96.36 | 2025 | Sprint Pns System |
| Abbvie INC. | $74.89 | 2022-2024 | Botox |
| Medtronic, INC. | $66.17 | 2023-2024 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $48.93 | 2025 | |
| Biodelivery Sciences International, INC. | $41.10 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $40.92 | 2019-2020 | |
| Pfizer INC. | $40.86 | 2021 | |
| Allergan, INC. | $30.28 | 2019-2021 | |
| Redhill Biopharma INC. | $29.26 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $23.22 | 2021 | |
| Avanos Medical | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Sanito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.